Immuno-compatibility of soft hydrophobic poly (n-butyl acrylate) networks with elastic moduli for regeneration of functional tissues

Clinical Hemorheology and Microcirculation

Volumn 50, Issue 1-2, 2012, Pages 131-142

  Roch, T ^a   Cui, J ^a   Kratz, K ^a   Lendlein, A ^a   Jung, F ^a  

^a INSTITUTE OF MATERIALS RESEARCH   (Germany)

Author keywords

biomaterial; butylacrylate; endotoxins; Immuno compatibility; polymer networks

Indexed keywords

ACRYLIC ACID BUTYL ESTER; ENDOTOXIN; POLYMER;

ANIMAL CELL; ARTICLE; BIOCOMPATIBILITY; BLOOD VESSEL PROSTHESIS; ELASTICITY; ENDOTHELIUM CELL; FIBROBLAST; HUMAN; HUMAN CELL; HYDROPHOBICITY; IMMUNE SYSTEM; IMMUNOBIOLOGY; IMPLANT; MONOCYTE; NONHUMAN; TISSUE REGENERATION; YOUNG MODULUS;

ACRYLATES; BIOCOMPATIBLE MATERIALS; CELL SURVIVAL; CYTOKINES; ELASTIC MODULUS; HUMANS; LEUKOCYTES; MACROPHAGES; POLYMERS; REACTIVE OXYGEN SPECIES; TISSUE ENGINEERING;

EID: 84856831546     PISSN: 13860291     EISSN: 18758622     Source Type: Journal    
DOI: 10.3233/CH-2010-1449     Document Type: Article

References (52)

1. J.C. Alves-Filho, A. de Freitas, F. Spiller, F.O. Souto and F.Q. Cunha, The role of neutrophils in severe sepsis, Shock 30(Suppl 1) (2008), 3-9.
2. J.M. Anderson, A. Rodriguez and D.T. Chang, Foreign body reaction to biomaterials, Semin Immunol 20 (2008), 86-100.
3. Anonymous, Ethical guidelines for publication in clinical hemorheology and microcirculation, Clin Hemorheol Microcirc 44 (2010), 1-2.
4. R. Aslam, et al., Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-alpha production in vivo, Blood 107 (2006), 637-641. (Pubitemid 43076388)
5. M.S. Baguneid, A.M. Seifalian, H.J. Salacinski, D. Murray, G. Hamilton and M.G. Walker, Tissue engineering of blood vessels, Br J Surg 93 (2006), 282-290.
6. J. Booth, H. Wilson, S. Jimbo and G. Mutwiri, Modulation of B cell responses by Toll-like receptors, Cell Tissue Res 343 (2011), 131-140.
7. G.D. Brown, J. Herre, D.L. Williams, J.A. Willment, A.S. Marshall and S. Gordon, Dectin-1 mediates the biological effects of beta-glucans, J Exp Med 197 (2003), 1119-1124. (Pubitemid 36570067)
8. D.E. Chenoweth, Complement activation during hemodialysis: Clinical observations, proposed mechanisms, and theoretical implications, Artif Organs 8 (1984), 281-290.
9. J. Cui, K. Kratz, B. Hiebl, F. Jung and A. Lendlein, Poly(n-butyl acrylate) networks with tailored mechanical properties designed as model substrates for mechano-responsive cells, Tissue Eng Pt A 17 (2011), 563-563.
10. J. Cui, K. Kratz, B. Hiebl, F. Jung and A. Lendlein, Soft poly(n-butyl acrylate) networks with tailored mechanical properties designed as substrates for in vitro models, Polym Advan Technol 22 (2011), 126-132.
11. A.J. Engler, M.A. Griffin, S. Sen, C.G. Bonnemann, H.L. Sweeney and D.E. Discher, Myotubes differentiate optimally on substrates with tissue-like stiffness: Pathological implications for soft or stiff microenvironments, J Cell Biol 166 (2004), 877-887. (Pubitemid 39249838)
12. A.J. Engler, S. Sen, H.L. Sweeney and D.E. Discher, Matrix elasticity directs stem cell lineage specification, Cell 126 (2006), 677-689. (Pubitemid 44233625)
13. S. Fillatreau, D. Gray and S.M. Anderton, Not always the bad guys: B cells as regulators of autoimmune pathology, Nat Rev Immunol 8 (2008), 391-397. (Pubitemid 351595221)
14. L.A. Flanagan, Y.E. Ju, B. Marg, M. Osterfield and P.A. Janmey, Neurite branching on deformable substrates, Neuroreport 13 (2002), 2411-2415. (Pubitemid 36143534)
15. E. Galkina and K. Ley, Immune and inflammatory mechanisms of atherosclerosis, Annu Rev Immunol 27 (2009), 165-197.
16. M.B. Gorbet and M.V. Sefton, Biomaterial-associated thrombosis: Roles of coagulation factors, complement, platelets and leukocytes, Biomaterials 25 (2004), 5681-5703. (Pubitemid 38624449)
17. M.B. Gorbet and M.V. Sefton, Endotoxin: The uninvited guest, Biomaterials 26 (2005), 6811-6817. (Pubitemid 41095506)
18. R. Gräsbeck and T. Alström, Reference values in laboratory medicine: The current state of the art, Wiley, Chichester, 1981.
19. T. Gustot, Multiple organ failure in sepsis: Prognosis and role of systemic inflammatory response, Curr Opin Crit Care 17 (2011), 153-159.
20. R. Hakim, Chapter 18 Complement activation by biomaterials, Cardiovasc Path 2 (1993), 187-197.
21. B. Hiebl, et al. Viability, Morphology and function of primary endothelial cells on Poly(n-Butyl Acrylate) networks having elastic moduli comparable to arteries, J Biomater Sci Polym Ed. (2011). In press, DOI: 10.1163/092050611X566144.
22. R.J. Johnson, Complement activation during extracorporeal therapy: Biochemistry, cell biology and clinical relevance, Nephrol Dial Transplant 9(Suppl 2) (1994), 36-45. (Pubitemid 24136236)
23. F. Jung, C. Wischke and A. Lendlein, Degradable, Multifunctional cardiovascular implants challenges and hurdles, MRS Bull 35 (2010), 607-613.
24. K.N. Kader and C.H. Coyle, Reactive oxygen and nitrogen species: Implications for cardiovascular device engineering, J Biomed Mater Res B Appl Biomater 83 (2007), 138-144. (Pubitemid 47463207)
25. R.Y. Kannan, H.J. Salacinski, M.J. Edirisinghe, G. Hamilton and A.M. Seifalian, Polyhedral oligomeric silsequioxanepolyurethane nanocomposite microvessels for an artificial capillary bed, Biomaterials 27 (2006), 4618-4626. (Pubitemid 43783225)
26. T. Kawai and S. Akira, The role of pattern-recognition receptors in innate immunity: Update on Toll-like receptors, Nat Immunol 11 (2010), 373-384.
27. V. Lampropoulou, et al., TLR-activated B cells suppress T cell-mediated autoimmunity, J Immunol 180 (2008), 4763-4773.
28. V. Lampropoulou, et al., Suppressive functions of activated B cells in autoimmune diseases reveal the dual roles of Toll-like receptors in immunity, Immunol Rev 233 (2010), 146-161.
29. H.Y. Lee and B.H. Oh, Aging and arterial stiffness, Circ J 74 (2010), 2257-2262.
30. A. Lendlein, Polymers in Biomedicine, Macromol Biosci 10 (2010), 993-997.
31. A. Lendlein, A.T. Neffe, B.F. Pierce and J.Vienken,Whyare so fewdegradable polymeric biomaterials currently established in clinical applications? Int J Artif Organs 34 (2011), 71-75.
32. A. Lendlein and C. Wischke, How to accelerate biomaterial development? Strategies to support the application of novel polymer-based biomaterials in implantable devices, Expert Rev Med Devic 8 (2011), 533-537.
33. M. Lovett, C. Cannizzaro, L. Daheron, B. Messmer, G. Vunjak-Novakovic and D.L. Kaplan, Silk fibroin microtubes for blood vessel engineering, Biomaterials 28 (2007), 5271-5279. (Pubitemid 47542340)
34. + monocytes/ macrophages with soft hydrophobic poly(n-butyl acrylate) networks with elastic moduli matched to human artheries Artif Organs (2011), in press, DOI: 10.111/j.1525-1594.2011.01410.x.
35. D.M. Mosser and J.P. Edwards, Exploring the full spectrum of macrophage activation, Nat Rev Immunol 8 (2008), 958-969.
36. R.J. Noelle and E.C. Nowak, Cellular sources and immune functions of interleukin-9, Nat Rev Immunol 10 (2010), 683-687.
37. S.M. Opal, Endotoxins and other sepsis triggers, Contrib Nephrol 167 (2010), 14-24.
38. S.M. Opal and C.T. Esmon, Bench-to-bedside review: Functional relationships between coagulation and the innate immune response and their respective roles in the pathogenesis of sepsis, Crit Care 7 (2003), 23-38. (Pubitemid 36204267)
39. D. Ricklin, G. Hajishengallis, K. Yang and J.D. Lambris, Complement: A key system for immune surveillance and homeostasis, Nat Immunol 11 (2010), 785-797.
40. W.A. Riley, R.W. Barnes, G.W. Evans and G.L. Burke, Ultrasonic measurement of the elastic modulus of the common carotid artery. The Atherosclerosis Risk in Communities (ARIC) Study, Stroke 23 (1992), 952-956.
41. T. Roch, B.F. Pierce, A. Zaupa, F. Jung, A.T. Neffe and A. Lendlein, Reducing the endotoxin burden of desaminotyrosineand desaminotyrosyl tyrosine-functionalized gelatin, Macromol Symp (2011), in press, DOI:10.1002/masy.201100048.
42. N. Scharnagl, S. Lee, B. Hiebl, A. Sisson and A. Lendlein, Design principles for polymers as substratum for adherent cells, J Mater Chem 20 (2010), 8789-8802.
43. N.V. Serbina, T. Jia, T.M. Hohl and E.G. Pamer, Monocyte-mediated defense against microbial pathogens, Annu Rev Immunol 26 (2008), 421-452. (Pubitemid 351600381)
44. V.P. Shastri and A. Lendlein, Materials in regenerative medicine, Adv Mater 21 (2009), 3231-3234.
45. A.D. Shepard, J.A. Gelfand, A.D. Callow and T.F. O'Donnell, Jr. Complement activation by synthetic vascular prostheses, J Vasc Surg 1 (1984), 829-838. (Pubitemid 15056080)
46. O. Takeuchi and S. Akira, Pattern recognition receptors and inflammation, Cell 140 (2010), 805-820.
47. M. Toda, T. Kitazawa, I. Hirata, Y. Hirano and H. Iwata, Complement activation on surfaces carrying amino groups, Biomaterials 29 (2008), 407-417. (Pubitemid 350100797)
48. J.A. Van Ginderachter, K.Movahedi, G. Hassanzadeh Ghassabeh, S. Meerschaut, A. Beschin, G. Raes and P. De Baetselier, Classical and alternative activation of mononuclear phagocytes: Picking the best of both worlds for tumor promotion, Immunobiology 211 (2006), 487-501.
49. O.J. Warren, et al., The inflammatory response to cardiopulmonary bypass: Part 1-mechanisms of pathogenesis, J Cardiothorac Vasc Anesth 23 (2009), 223-231.
50. K.L. Williams, Endotoxins: Pyrogens, LAL testing and depyrogenation, Informa Healthcare, New York, 2007.
51. Z. Xia and J.T. Triffitt, A review on macrophage responses to biomaterials, Biomed Mater 1 (2006), R1-R9.
52. G. Zhang, et al., Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway, J Immunol 182 (2009), 7997-8004.